Cancer

Researchers Identify Best Drug Therapy for Rare, Aggressive Pancreatic Cancer

Each year, about 200 to 400 Americans develop acinar cell carcinoma, a rare form of pancreatic cancer that has no effective standard of care.

Publish Date: 6/10/2016

Minimally Invasive Inguinal Lymph Node Dissection (MILND)

James W. Jakub, M.D., demonstrates the safe, feasible operative technique of minimally invasive inguinal lymph node dissection (MILND) in a patient with melanoma.

Publish Date: 4/28/2015

Faster Tumor Analysis Software Speeds Cancer Discoveries

With the glut of data generated through next-generation sequencing, interpretation has become the new bottleneck in scientific discovery and clinical application.

Publish Date: 10/8/2014

Methylated DNA Markers and Whole Body Cancer Screening

John B. Kisiel, M.D., a gastroenterologist at Mayo Clinic's campus in Rochester, Minnesota, discusses a study that identified the source of cancer in patients’ gastrointestinal tracts by analyzing DNA markers from tumors.

Publish Date: 8/5/2015

Ibrutinib With Chemotherapy Offers Longer Life to Patients With B-Cell Cancers

Researchers found that a combination of ibrutinib and chemotherapy reduced the risk of death or cancer progression by 80 percent in patients with previously treated chronic lymphocytic leukemia.

Publish Date: 8/5/2015

play 1 2 3 4 5

All
Cancer
(88)

first < previous 2 3 4 5 6 7 8 9 10 11 next > last
video
EUS Aids Diagnosis and Treatment of Pancreatic Cysts

Mark D. Topazian, M.D., of the Division of Gastroenterology and Hepatology at Mayo Clinic in Rochester, Minn., discusses endoscopic diagnosis and management of pancreatic cysts, including efforts to refine criteria for resection of mucinous cysts and EUS.

View Video

video
Proton Therapy has Advantages Over IMRT for Advanced Head and Neck Cancers

Radiation oncologists at Mayo Clinic reviewed the world's literature on outcomes of proton beam therapy in the treatment of a variety of advanced head and neck cancers of the skull base.

View Video

video
New Model To Assess Breast Cancer Risk More Accurate Than Current Option

A new breast cancer risk prediction model combining histologic features of biopsied breast tissue from women with benign breast disease and individual patient demographic information more accurately classified breast cancer risk than the current screening standard.

View Video

video
Researchers Locate Master Cutoff Switch for Cancer-Causing HER2 Protein

Herceptin has been touted as a wonder drug for women with HER2-positive breast cancer, an aggressive form of the disease that is fueled by excess production of the HER2 protein.

View Video

video
Methylated DNA Markers and Whole Body Cancer Screening

John B. Kisiel, M.D., a gastroenterologist at Mayo Clinic's campus in Rochester, Minnesota, discusses a study that identified the source of cancer in patients’ gastrointestinal tracts by analyzing DNA markers from tumors.

View Video

video
Large Waist Linked to Poor Health, Even Among Those in Healthy Body Mass Index Ranges

Having a big belly has consequences beyond trouble squeezing into your pants. It’s detrimental to your health, even if you have a healthy body mass index (BMI), a new international collaborative study has found.

View Video

video
Mayo Clinic Researcher On Factors to Improve Breast Cancer Risk Prediction

Mayo Clinic researcher Fergus Couch, Ph.D, discusses a study show that combined 77 common genetic variants into a single risk factor that can be used to improve the identification of women with an elevated risk of breast cancer.

View Video

video
Mayo researchers developing new way to screen for endometrial cancer - Mayo Clinic

Researchers at Mayo Clinic have shown that it is possible to detect endometrial cancer using tumor DNA picked up by ordinary tampons.

View Video

first < previous 2 3 4 5 6 7 8 9 10 11 next > last

Refer a patient

  1. Arizona
    866-629-6362
  2. Florida
    800-634-1417
  3. Minnesota
    800-533-1564

Online referrals

Referring your patient

Download a referral form